Page 7 - textbook5chapters
P. 7
xx Contents
164. Targeted Therapy in 179. Pelvic Irradiation: Acute and Late Toxicity . . . . . 1425
Gynaecologic Oncology . . . . . . . . . . . . . . . . . . . . . . 1281
Alexandra Taylor, MBBS, MD, Andreia Fernandes, RN, MSc
Maurie Markman, MD Pardeep Kumar, MB, FRCS, PhD, Ann Muls, RN, Msc
165. Cytoreductive Surgery and 180. Management of Radiotherapy
Perioperative Hyperthermic Complications in Gynaecological
Chemotherapy for Peritoneal Metastases . . . . . 1286 Malignancies Treatments . . . . . . . . . . . . . . . . . . . . 1437
Paul H. Sugarbaker, MD, FACS, FRCS Banu Atalar, MD, Senem Alanyali, MD
Zeynep Ozsaran, MD, Enis Ozyar, MD
166. Technique of Intraperitoneal Chemotherapy:
Normothermic and Hyperthermic . . . . . . . . . . . . 1293 SECTION XII:
PALLIATIVE CARE IN GYNAECOLOGIC ONCOLOGY
Asima Mukhopadhyay, MD, MRCOG, PhD, MSc
C. William Helm, MB.BChir, FRCS 181. Challenges and Opportunities in
Palliative Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1449
167. Cytotoxic Trials by the Gynaecologic
Oncology Group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1308 Giovanni Elia, MD, Frank D. Ferris, MD, FAAHPM, FAACE
Siriwan Tangjitgamol, MD, John Kavanagh, MD 182. Management of Chemotherapy
Induced Nausea and Vomiting (CINV) . . . . . . . . . 1459
168. Novel Biologic Therapies in The
Treatment of Epithelial Ovarian Cancer . . . . . . . 1323 Gudrun Kreye, MD, Eva –Katharina Masel, MD
Sophie Schur, MD
John W. Moroney, MD
Robert L. Coleman, MD 183. Pain Palliation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1470
169. PARP Inhibitors and Homologous Nesrin Bozdogan Ozyilkan, MD
Recombination Deficiency . . . . . . . . . . . . . . . . . . . 1335
184. Nutrition: The Relevance in
Rowan Miller, MA, PhD, MRCP Gynaecological Cancer . . . . . . . . . . . . . . . . . . . . . . . 1482
Jonathan Ledermann, BSc, MD, FRCP
Paula Ravasco, Nutricionist, MSc, MD, PhD
170. Current Immunotherapeutic Approaches to
Ovarian Cancer Treatment . . . . . . . . . . . . . . . . . . . 1343 185. Complementary, Alternative and
Integrative Medicine Use Among
Venkatesh Krishnan, MD, Cariad Chester, MD Patients With Gynaecological Cancers . . . . . . . . 1489
Holbrook Kohrt, MD, Jonathan S. Berek, MD
Oliver Dorigo, MD Kjell Bergfeldt, MD, PhD, Johanna Hök, MSc Pharm, PhD
171. Management of Chemotherapy-Induced 186. Psychological Support . . . . . . . . . . . . . . . . . . . . . . . 1495
Adverse Effects . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1354
Joachim Weis, MD, Annette Hasenburg, MD
Eleonora Teplinsky, MD, Thomas J. Herzog, MD
187. Euthanasia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1500
172. Management of Chemotherapy
Complications in Gynaecological A. Peter M. Heintz, MD, PhD, Nicole B. Swarte, MD, PhD
Malignancy Treatments . . . . . . . . . . . . . . . . . . . . . . 1366
188. Quality of Life (QoL) in Oncologic Patients . . . . 1505
Alexandru Calin Grigorescu, MD, PhD, RDI
Adriana Bermudez, MD, PhD
SECTION XI:
RADIATION ONCOLOGY 189. Lymphocele, Lymphorrhea After
Lymphadenectomy . . . . . . . . . . . . . . . . . . . . . . . . . . 1507
173. Principles of Radiation Therapy in
Gynaecologic Oncology . . . . . . . . . . . . . . . . . . . . . . 1375 Ahmet Baris Guzel, MD, Umran Kucukgoz Gulec, MD,
Mehmet Ali Vardar, MD, Aytekin Altintas, MD
Catheryn M. Yashar, MD, FACRO, Daniel J. Scanderbeg, PhD
Sunil J. Advani, MD SECTION XIII:
RARE GYNAECOLOGICAL CANCERS
174. Current Radiotherapy Protocols in
Gynaecologic Oncology . . . . . . . . . . . . . . . . . . . . . . 1383 190. Rare Gynaecological Cancers:
An Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1515
Joanne Jang, MD, Akila N. Viswanathan, MD, MPH
Nicholas Reed, MD
175. Cyberknife Stereotactic Body
Radiosurgery in Gynaecologic Carcinomas . . . . 1389 191. GCIG Rare Tumor Consensus
Review & Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . 1520
Charles A. Kunos, MD, PhD
Isabelle Ray-Coquard, MD, PhD, Jonathan A. Ledermann, MD
176. Image Guided vs. Conventional Radiation Philipp Harter, MD, Michael Friedlander, MD, PhD
Therapy in Gynaecologic Cancers . . . . . . . . . . . . . 1396 Frederic Amant, MD, PhD Aikou Okamoto, MD, PhD
Eva Gómez-García, MD, Charlie Gourley, MD, PhD
Alina Sturdza, MD, FRCPC, Maximilian Schmid, MD Martee Hensley, MD, Patricia Pautier, MD Keiichi Fujiwara, MD, PhD
Richard Pötter, MD Domenica Lorusso, MD, Satoru Sagae, MD
Akila N. Viswanathan, MD, MPH, Mario M. Leitao Jr, MD
177. Chemoradiotherapy: Neoadjuvant, Toyomi Satoh, MD, PhD, Nick Reed, MD, Jubilee Brown, MD,
Concomitant, Sequential, or Dominique Berton Rigaud, MD
Monomodality Treatment? . . . . . . . . . . . . . . . . . . . 1405 Rosalind Glasspool, MBBS, PhD, FRCP
Eric Pujade Lauraine, MD, PhD
Patricia J. Eifel, MD
178. Gynaecological Brachytherapy . . . . . . . . . . . . . . . 1413
Niraj H. Pahlajani, MD, Matthew M. Harkenrider, MD
Fiori Alite, MD, William Small Jr., MD, FACRO FACR, FASTRO
